These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31505645)

  • 41. Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellín, Colombia 2010-2011.
    Maldonado NA; Cano LE; De Bedout C; Arbeláez CA; Roncancio G; Tabares AM; Robledo CG; Robledo J;
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):280-6. PubMed ID: 24666706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
    Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
    J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
    Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
    Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
    Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
    Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.
    Pfaller MA; Diekema DJ; Jones RN; Messer SA; Hollis RJ;
    J Clin Microbiol; 2002 Mar; 40(3):852-6. PubMed ID: 11880404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
    Zhang L; Zhou S; Pan A; Li J; Liu B
    Int J Infect Dis; 2015 Apr; 33():1-4. PubMed ID: 25541294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study.
    Xiao M; Chen SC; Kong F; Xu XL; Yan L; Kong HS; Fan X; Hou X; Cheng JW; Zhou ML; Li Y; Yu SY; Huang JJ; Zhang G; Yang Y; Zhang JJ; Duan SM; Kang W; Wang H; Xu YC
    J Infect Dis; 2020 Mar; 221(Suppl 2):S139-S147. PubMed ID: 32176789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
    Morris AJ; Rogers K; McKinney WP; Roberts SA; Freeman JT
    J Glob Antimicrob Resist; 2018 Sep; 14():72-77. PubMed ID: 29486358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antifungal Susceptibility of Clinical Yeast Isolates from a Large Canadian Reference Laboratory and Application of Whole-Genome Sequence Analysis To Elucidate Mechanisms of Acquired Resistance.
    McTaggart LR; Cabrera A; Cronin K; Kus JV
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.
    Li F; Wu L; Cao B; Zhang Y; Li X; Liu Y
    BMC Infect Dis; 2013 Jul; 13():353. PubMed ID: 23899244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
    Mokaddas EM; Al-Sweih NA; Khan ZU
    J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H; Xu YC; Hsueh PR
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
    Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
    J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.